• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Md. health departments ready to assist residents with naloxone device recall

    Atomizer manufacturer finds specific lot numbers can provide insufficient dosages 

    Baltimore, MD (November 18, 2016) – In response to Teleflex Medical Inc.’s medical device recall for specific lots of MAD Nasal Intranasal Mucosal Atomizer Device, the Department of Health and Mental Hygiene urges Marylanders who have received a naloxone kit to check their atomizer for recalled lot numbers.  
    Teleflex received complaints that certain atomizers were delivering medication in a stream rather than a fully atomized plume. Although naloxone still will act to reverse an opioid overdose, defective devices may cause a risk of under-dosing of naloxone during nasal administration. The company issued the recall on October 27, 2016. Since then, Health and Mental Hygiene has conferred with local health departments to see if corresponding devices had been distributed through the Overdose Response Program. While it has been confirmed that some of the corresponding devices have been distributed, the department has not received any reports of product malfunctions. 
    Members of the public who obtained naloxone kits with an atomizer delivery device in 2016 are encouraged to check their device for recall. There is a lot number on the plastic packaging of the atomizer. If the lot number on the atomizer matches one on the list below, you may contact your local health department for a replacement.  Please note the recall is for the atomizer only and not naloxone. The medication should not be discarded. 
    In response to rising overdose deaths, the State initiated the Overdose Response Program (ORP) in 2014 to provide overdose education and naloxone to the public. The ORP provides specialized, in-depth, hands-on training on opioid overdoses and naloxone administration. Since 2014, more than 60 local training programs have been authorized by Health and Mental Hygiene, including all local health departments and some law enforcement agencies, community-based programs and treatment agencies. In 2015, the department issued a standing order to allow pharmacists to dispense naloxone to ORP-certified individuals. To date, nearly 37,000 individuals have been trained in naloxone administration, and programs have provided more than 40,000 doses of naloxone at the time of training.
    For more information about naloxone, the Overdose Response Program, and contact information for your local health department, please visit https://goo.gl/JnVnyB.  Health departments are also listed on our website at https://goo.gl/ekGg28.

    Teleflex Medical Inc. has issued a recall for the following lot numbers of MAD300 devices:
    Marylanders who need help finding substance-use-disorder treatment resources should visit http://goo.gl/nIfGm0 or call the Maryland Crisis Hotline, which provides 24/7 support, at 1-800-422-0009. For information on many of the policies currently implemented to fight addiction and overdose in Maryland, see http://goo.gl/KvEzQw. If you know of someone in need of treatment for a substance use disorder, treatment facilities can be located by location and program characteristics on our page at http://goo.gl/rbGF6S.